Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 970-979

  Maugeri, Norma ^a   Rovere Querini, Patrizia ^a   Slavich, Massimo ^a   Coppi, Giovanni ^a   Doni, Andrea ^b   Bottazzi, Barbara ^b   Garlanda, Cecilia ^b   Cianflone, Domenico ^a   Maseri, Attilio ^a   Mantovani, Alberto ^b   Manfredi, Angelo A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; FIBRINOGEN; PADGEM PROTEIN; PENTRAXIN 3;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPLETION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UPREGULATION;

ACUTE-PHASE PROTEINS; ADULT; AGED; C-REACTIVE PROTEIN; CELL COMMUNICATION; CORONARY THROMBOSIS; CYTOPLASMIC GRANULES; FEMALE; G0 PHASE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET ACTIVATION; SERUM AMYLOID P-COMPONENT;

EID: 79960490361     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100261     Document Type: Article

References (54)

1. Manfredi, A. A., P. Rovere-Querini, B. Bottazzi, C. Garlanda, and A. Mantovani. 2008. Pentraxins, humoral innate immunity and tissue injury. Curr. Opin. Immunol. 20: 538-544.
2. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
3. Inforzato, A., C. Baldock, T. A. Jowitt, D. F. Holmes, R. Lindstedt, M. Marcellini, V. Rivieccio, D. C. Briggs, K. E. Kadler, A. Verdoliva, et al. 2010. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J. Biol. Chem. 285: 17681-17692.
4. Klouche, M., G. Peri, C. Knabbe, H. H. Eckstein, F. X. Schmid, G. Schmitz, and A. Mantovani. 2004. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175: 221-228. (Pubitemid 38942901)
5. Mallat, Z., and A. Tedgui. 2008. HDL, PTX3, and vascular protection. Arterioscler. Thromb. Vasc. Biol. 28: 809-811.
6. Rolph, M. S., S. Zimmer, B. Bottazzi, C. Garlanda, A. Mantovani, and G. K. Hansson. 2002. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22: e10-e14.
7. Savchenko, A., M. Imamura, R. Ohashi, S. Jiang, T. Kawasaki, G. Hasegawa, I. Emura, H. Iwanari, M. Sagara, T. Tanaka, et al. 2008. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J. Pathol. 215: 48-55. (Pubitemid 351619875)
8. Norata, G. D., C. Garlanda, and A. L. Catapano. 2010. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc. Med. 20: 35-40.
9. Fazzini, F., G. Peri, A. Doni, G. Dell'Antonio, E. Dal Cin, E. Bozzolo, F. D'Auria, L. Praderio, G. Ciboddo, M. G. Sabbadini, et al. 2001. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 44: 2841-2850. (Pubitemid 34016204)
10. van Rossum, A. P., H. H. Pas, F. Fazzini, M. G. Huitema, P. C. Limburg, M. F. Jonkman, and C. G. Kallenberg. 2006. Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum. 54: 986-991.
11. Maugeri, N., M. Baldini, P. Rovere-Querini, A. Maseri, M. G. Sabbadini, and A. A. Manfredi. 2009. Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity 42: 386-388.
12. Kotooka, N., T. Inoue, S. Aoki, M. Anan, H. Komoda, and K. Node. 2008. Prognostic value of pentraxin 3 in patients with chronic heart failure. Int. J. Cardiol. 130: 19-22.
13. Suzuki, S., Y. Takeishi, T. Niizeki, Y. Koyama, T. Kitahara, T. Sasaki, M. Sagara, and I. Kubota. 2008. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am. Heart J. 155: 75-81.
14. Kotooka, N., T. Inoue, D. Fujimatsu, T. Morooka, S. Hashimoto, Y. Hikichi, T. Uchida, A. Sugiyama, and K. Node. 2008. Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. Atherosclerosis 197: 368-374. (Pubitemid 351273259)
15. Peri, G., M. Introna, D. Corradi, G. Iacuitti, S. Signorini, F. Avanzini, F. Pizzetti, A. P. Maggioni, T. Moccetti, M. Metra, et al. 2000. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102: 636-641. (Pubitemid 30640663)
16. Latini, R., A. P. Maggioni, G. Peri, L. Gonzini, D. Lucci, P. Mocarelli, L. Vago, F. Pasqualini, S. Signorini, D. Soldateschi, et al; Lipid Assessment Trial Italian Network (LATIN) Investigators. 2004. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110: 2349-2354.
17. Matsui, S., J. Ishii, F. Kitagawa, A. Kuno, K. Hattori, M. Ishikawa, M. Okumura, S. Kan, T. Nakano, H. Naruse, et al. 2010. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 210: 220-225.
18. Jenny, N. S., A. M. Arnold, L. H. Kuller, R. P. Tracy, and B. M. Psaty. 2009. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 29: 594-599.
19. Salio, M., S. Chimenti, N. De Angelis, F. Molla, V. Maina, M. Nebuloni, F. Pasqualini, R. Latini, C. Garlanda, and A. Mantovani. 2008. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation 117: 1055-1064.
20. Norata, G. D., P. Marchesi, V. K. Pulakazhi Venu, F. Pasqualini, A. Anselmo, F. Moalli, I. Pizzitola, C. Garlanda, A. Mantovani, and A. L. Catapano. 2009. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120: 699-708.
21. Deban, L., S. Jaillon, C. Garlanda, B. Bottazzi, and A. Mantovani. 2011. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 343: 237-249.
22. McEver, R. P. 2010. Rolling back neutrophil adhesion. Nat. Immunol. 11: 282-284.
23. Maugeri, N., P. Rovere-Querini, V. Evangelista, C. Covino, A. Capobianco, M. T. Bertilaccio, A. Piccoli, L. Totani, D. Cianflone, A. Maseri, and A. A. Manfredi. 2009. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and b2 integrin-dependent cell clearance program. Blood 113: 5254-5265.
24. Manfredi, A. A., P. Rovere-Querini, and N. Maugeri. 2010. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr. Opin. Hematol. 17: 3-8.
25. Looney, M. R., J. X. Nguyen, Y. Hu, J. A. Van Ziffle, C. A. Lowell, and M. A. Matthay. 2009. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Invest. 119: 3450-3461.
26. Semple, J. W., and J. Freedman. 2010. Platelets and innate immunity. Cell. Mol. Life Sci. 67: 499-511.
27. Evangelista, V., Z. Pamuklar, A. Piccoli, S. Manarini, G. Dell'elba, R. Pecce, N. Martelli, L. Federico, M. Rojas, G. Berton, et al. 2007. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood 109: 2461-2469.
28. Zarbock, A., H. Müller, Y. Kuwano, and K. Ley. 2009. PSGL-1-dependent myeloid leukocyte activation. J. Leukoc. Biol. 86: 1119-1124.
29. Jaillon, S., G. Peri, Y. Delneste, I. Frémaux, A. Doni, F. Moalli, C. Garlanda, L. Romani, H. Gascan, S. Bellocchio, et al. 2007. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J. Exp. Med. 204: 793-804.
30. Buffon, A., L. M. Biasucci, G. Liuzzo, G. D'Onofrio, F. Crea, and A. Maseri. 2002. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347: 5-12.
31. Biasucci, L. M., G. D'Onofrio, G. Liuzzo, G. Zini, C. Monaco, G. Caligiuri, M. Tommasi, A. G. Rebuzzi, and A. Maseri. 1996. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J. Am. Coll. Cardiol. 27: 611-616.
32. Bekkers, S. C., S. K. Yazdani, R. Virmani, and J. Waltenberger. 2010. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J. Am. Coll. Cardiol. 55: 1649-1660.
33. Oostingh, G. J., R. J. Ludwig, S. Enders, S. Grüner, G. Harms, W. H. Boehncke, B. Nieswandt, R. Tauber, and M. P. Schön. 2007. Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J. Invest. Dermatol. 127: 90-97.
34. Botto, N., S. Sbrana, G. Trianni, M. G. Andreassi, M. Ravani, A. Rizza, A. Al-Jabri, C. Palmieri, and S. Berti. 2007. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon? Int. J. Cardiol. 117: 123-130.
35. Furie, B., and B. C. Furie. 2008. Mechanisms of thrombus formation. N. Engl. J. Med. 359: 938-949.
36. Michelson, A. D. 2010. Antiplatelet therapies for the treatment of cardiovascular disease. Nat. Rev. Drug Discov. 9: 154-169.
37. Ferrante, G., M. Nakano, F. Prati, G. Niccoli, M. T. Mallus, V. Ramazzotti, R. A. Montone, F. D. Kolodgie, R. Virmani, and F. Crea. 2010. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 122: 2505-2513.
38. Maugeri, N., G. de Gaetano, M. Barbanti, M. B. Donati, and C. Cerletti. 2005. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin. Haematologica 90: 833-839. (Pubitemid 40897226)
39. Rovere, P., G. Peri, F. Fazzini, B. Bottazzi, A. Doni, A. Bondanza, V. S. Zimmermann, C. Garlanda, U. Fascio, M. G. Sabbadini, et al. 2000. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96: 4300-4306.
40. Piccardoni, P., R. Sideri, S. Manarini, A. Piccoli, N. Martelli, G. de Gaetano, C. Cerletti, and V. Evangelista. 2001. Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood 98: 108-116.
41. Maugeri, N., P. Rovere-Querini, M. Baldini, M. G. Sabbadini, and A. A. Manfredi. 2009. Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin. Exp. Immunol. 156: 395-404.
42. Ferri, L. A., N. Maugeri, P. Rovere-Querini, A. Calabrese, E. Ammirati, D. Cianflone, A. Maseri, and A. A. Manfredi. 2009. Anti-inflammatory action of apoptotic cells in patients with acute coronary syndromes. Atherosclerosis 205: 391-395.
43. Linden, M. D., M. I. Furman, A. L. Frelinger, III, M. L. Fox, M. R. Barnard, Y. Li, K. Przyklenk, and A. D. Michelson. 2007. Indices of platelet activation and the stability of coronary artery disease. J. Thromb. Haemost. 5: 761-765.
44. Furman, M. I., M. R. Barnard, L. A. Krueger, M. L. Fox, E. A. Shilale, D. M. Lessard, P. Marchese, A. L. Frelinger, III, R. J. Goldberg, and A. D. Michelson. 2001. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J. Am. Coll. Cardiol. 38: 1002-1006.
45. Michelson, A. D., M. R. Barnard, L. A. Krueger, C. R. Valeri, and M. I. Furman. 2001. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104: 1533-1537.
46. Dominguez-Rodriguez, A., S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez, and J. C. Kaski. 2008. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am. J. Cardiol. 101: 1537-1540.
47. Yunoki, K., T. Naruko, R. Komatsu, N. Shirai, M. Nakagawa, K. Sugioka, Y. Ikura, K. F. Kusano, A. Itoh, K. Haze, et al. 2010. Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction. Am. J. Cardiol. 105: 922-929.
48. Baker, J. O., J. Reinhold, S. Redwood, and M. S. Marber. 2011. Troponins: redefining their limits. Heart 97: 447-452.
49. Napoleone, E., A. di Santo, G. Peri, A. Mantovani, G. de Gaetano, M. B. Donati, and R. Lorenzet. 2004. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J. Leukoc. Biol. 76: 203-209.
50. Napoleone, E., A. Di Santo, A. Bastone, G. Peri, A. Mantovani, G. de Gaetano, M. B. Donati, and R. Lorenzet. 2002. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler. Thromb. Vasc. Biol. 22: 782-787.
51. Zarbock, A., and K. Ley. 2009. The role of platelets in acute lung injury (ALI). Front. Biosci. 14: 150-158.
52. Zarbock, A., R. K. Polanowska-Grabowska, and K. Ley. 2007. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 21: 99-111. (Pubitemid 46428465)
53. Zhang, Q., M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki, and C. J. Hauser. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
54. Manfredi, A. A., and P. Rovere-Querini. 2010. The mitochondrion: a Trojan horse that kicks off inflammation? N. Engl. J. Med. 362: 2132-2134.